Chargement en cours...
Revaprazan, a novel acid pump antagonist, exerts anti-inflammatory action against Helicobacter pylori-induced COX-2 expression by inactivating Akt signaling
Chronic gastric inflammation developing after Helicobacter pylori (H. pylori) infection is responsible for either dyspeptic symptom relevant to gastritis/peptic ulcer or gastric tumorigenesis, in which acid suppressants, especially proton pump inhibitors (PPIs), play role in relieving dyspepsia as w...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
the Society for Free Radical Research Japan
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3432830/ https://ncbi.nlm.nih.gov/pubmed/22962522 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3164/jcbn.11-94 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|